SECAUCUS, N.J. and BOSTON, June 11, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that it has completed its previously announced ...

Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce ...

PathAI, Inc., a leading AI-powered precision pathology company, today announced an expanded and exclusive relationship with Roche Tissue Diagnostics (RTD) that will bring AI-enabled interpretation to ...

BOSTON--(BUSINESS WIRE)--PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. The initial work within this extended ...

First-of-its-kind digital pathology network powered by PathAI’s AISight® platform expands access to latest AI products, unlocks real-world data value, and fuels collaborative research with biopharma ...

(MENAFN- GlobeNewsWire - Nasdaq) Collaboration includes use of PathAI's AISight®1 digital pathology image management system at Northwestern Medicine and joint efforts in research, clinical innovation, ...

If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI’s (ahem) path forward appears to be paved in gold. The five-year-old startup ...